These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 23984554)

  • 1. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of Yersinia pestis to antimicrobial agents.
    Galimand M; Carniel E; Courvalin P
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3233-6. PubMed ID: 17005799
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
    Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
    Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
    Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
    Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A method for the accelerated determination of the virulence of Y. pestis cultures in the epizootiological examination of natural plague foci].
    Orlov GS
    Voen Med Zh; 1993 Feb; (2):39-41, 80. PubMed ID: 8498023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
    Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
    Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plague: Recognition, Treatment, and Prevention.
    Yang R
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29070654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yersinia pestis and approaches to targeting its outer protein H protein-tyrosine phosphatase (YopH).
    Bahta M; Burke TR
    Curr Med Chem; 2012; 19(33):5726-34. PubMed ID: 22934808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonic Plague: The Darker Side of Yersinia pestis.
    Pechous RD; Sivaraman V; Stasulli NM; Goldman WE
    Trends Microbiol; 2016 Mar; 24(3):190-197. PubMed ID: 26698952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.